(Q46890609)

26 December 2017

http://europepmc.org/abstract/MED/16407551

title

Estrogen prevents neuroprotection by caffeine in the mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6674425&resulttype=core&format=json

11 May 2020

1 reference

1 reference

Michael A Schwarzschild

7

object named as

Michael A Schwarzschild

2 references

26 December 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6674425&resulttype=core&format=json

11 May 2020

5

Alberto Ascherio

2 references

26 December 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6674425&resulttype=core&format=json

11 May 2020

author name string

Kui Xu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6674425&resulttype=core&format=json

11 May 2020

Yuehang Xu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6674425&resulttype=core&format=json

11 May 2020

Deborah Brown-Jermyn

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6674425&resulttype=core&format=json

11 May 2020

Jiang-Fan Chen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6674425&resulttype=core&format=json

11 May 2020

Dean E Dluzen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6674425&resulttype=core&format=json

11 May 2020

language of work or name

English

0 references

publication date

1 January 2006

1 reference

26 December 2017

http://europepmc.org/abstract/MED/16407551

published in

Journal of Neuroscience

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6674425&resulttype=core&format=json

11 May 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6674425&resulttype=core&format=json

11 May 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6674425&resulttype=core&format=json

11 May 2020

page(s)

535-541

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6674425&resulttype=core&format=json

Actions of caffeine in the brain with special reference to factors that contribute to its widespread use.

11 May 2020

cites work

1 reference

12 December 2020

Parkinson's disease in twins: a follow-up study

1 reference

12 December 2020

Inhibition of caffeine metabolism by estrogen replacement therapy in postmenopausal women

1 reference

12 December 2020

Association of coffee and caffeine intake with the risk of Parkinson disease

1 reference

12 December 2020

Parkinson's disease and CYP1A2 activity

1 reference

12 December 2020

Smoking, alcohol, and coffee consumption preceding Parkinson's disease: a case-control study.

1 reference

12 December 2020

Parkinson's disease and parkinsonism in a longitudinal study: two-fold higher incidence in men. ILSA Working Group. Italian Longitudinal Study on Aging.

1 reference

12 December 2020

Tamoxifen abolishes estrogen's neuroprotective effect upon methamphetamine neurotoxicity of the nigrostriatal dopaminergic system

1 reference

12 December 2020

Neuroprotection by caffeine and A(2A) adenosine receptor inactivation in a model of Parkinson's disease.

1 reference

12 December 2020

Neuroprotective properties of 17beta-estradiol, progesterone, and raloxifene in MPTP C57Bl/6 mice

1 reference

12 December 2020

Prospective study of caffeine consumption and risk of Parkinson's disease in men and women.

1 reference

12 December 2020

Caffeine's neuroprotection against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity shows no tolerance to chronic caffeine administration in mice

1 reference

12 December 2020

Caffeine, postmenopausal estrogen, and risk of Parkinson's disease

1 reference

12 December 2020

The measurement of adenosine and estrogen receptor expression in rat brains following ovariectomy using quantitative PCR analysis.

1 reference

12 December 2020

Neuroprotective agents for clinical trials in Parkinson's disease: a systematic assessment

1 reference

12 December 2020

Repeated estradiol treatment prevents MPTP-induced dopamine depletion in male mice

1 reference

12 December 2020

Biotransformation of caffeine, paraxanthine, theobromine and theophylline by cDNA-expressed human CYP1A2 and CYP2E1

1 reference

12 December 2020

Impact of the selective estrogen receptor modulator, raloxifene, on neuronal survival and outgrowth following toxic insults associated with aging and Alzheimer's disease

1 reference

12 December 2020

Estrogen attenuates neuronal excitability in the insular cortex following middle cerebral artery occlusion.

1 reference

12 December 2020

No evidence for heritability of Parkinson disease in Swedish twins.

1 reference

12 December 2020

Acute effects of 17beta-estradiol on the extracellular concentration of excitatory amino acids and energy metabolites during transient cerebral ischemia in male rats

1 reference

12 December 2020

Coffee consumption, gender, and Parkinson's disease mortality in the cancer prevention study II cohort: the modifying effects of estrogen

1 reference

12 December 2020

Protective effect of caffeine against neurodegeneration in a model of Parkinson's disease in rat: behavioral and histochemical evidence

1 reference

12 December 2020

Therapeutic potential of adenosine A(2A) receptor antagonists in Parkinson's disease

1 reference

12 December 2020

Estrogen mediated inhibition of dopamine transport in the striatum: regulation by G alpha i/o.

1 reference

12 December 2020

The relationships between aging, monoamine oxidase, striatal dopamine and the effects of MPTP in C57BL/6 mice: a critical reassessment

1 reference

12 December 2020

Striatal D-2 dopamine agonist binding sites fluctuate during the rat estrous cycle

1 reference

12 December 2020

Impairment of caffeine clearance by chronic use of low-dose oestrogen-containing oral contraceptives.

1 reference

12 December 2020

Impaired elimination of caffeine by oral contraceptive steroids

1 reference

12 December 2020

Modulation by estradiol and progesterone of the GTP effect on striatal D-2 dopamine receptors

1 reference

12 December 2020

Caffeine metabolism by human hepatic cytochromes P450: contributions of 1A2, 2E1 and 3A isoforms

1 reference

12 December 2020

Estrogen alters MPTP-induced neurotoxicity in female mice: effects on striatal dopamine concentrations and release.

1 reference

12 December 2020

The dopamine-depleting effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in CD-1 mice are gender-dependent.

1 reference

12 December 2020

Roles of cytochromes P450 1A2 and 3A4 in the oxidation of estradiol and estrone in human liver microsomes

1 reference

12 December 2020

The Impact of Gender and Estrogen on Striatal Dopaminergic Neurotoxicity

1 reference

12 December 2020

Parkinson disease in twins: an etiologic study

1 reference

12 December 2020

10.1523/JNEUROSCI.3008-05.2006

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6674425&resulttype=core&format=json

11 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6674425&resulttype=core&format=json

11 May 2020

1 reference